Sievers H, Sievers J, Baumgarten H G, König N, Schlossberger H G
Brain Res. 1983 Sep 19;275(1):23-45. doi: 10.1016/0006-8993(83)90414-6.
The present report describes the distribution of tritium label after injection of newborn rats with [3H]6-hydroxydopamine ([3H]6-OHDA). The animals were injected either intracisternally (i.c.) or subcutaneously (s.c.), with or without pretreatment with nomifensine, which blocks the high-affinity uptake of both noradrenaline (NA) and dopamine (DA), and sacrificed at intervals from 40 min to 24 h post-injection (p.i.). In i.c. injected animals, tritium label is demonstrable as early as 40 min p.i. in neurons of all known NA and DA cell groups. In NA neurons, it is taken up into cell body, dendrites, preterminal and terminal axons. The intensity of neuronal labeling is highest within the first 4 h p.i. and decreases in most neurons with longer postinjection intervals. A significant proportion of both NA and DA neurons degenerate beginning 6 h p.i., the majority show morphological signs of the axon reaction 24 h p.i. Uptake of [3H]6-OHDA into serotonergic and non-catecholaminergic neurons is not demonstrable. [3H]6-OHDA is accumulated by the following extraneuronal cells of the CNS: ependymal cells, epithelial cells of the choroid plexus, subependymal macrophages, smooth muscle cells in the wall of large intraparenchymal blood vessels, meningeal cells and glial cells. The time course of accumulation and disappearance of the label varies among these extraneuronal elements. The meningeal cells show the highest labeling intensity and degenerate within 24 h p.i. After pretreatment of the animals with nomifensine, the uptake of [3H]6-OHDA into NA and DA neurons is totally blocked; by contrast uptake of the labeled drug into extraneuronal cells is not prevented. These findings show that [3H]6-OHDA is not only accumulated by neurons possessing the high-affinity uptake for NA or DA, but by numerous other, extraneuronal cells which also participate in the metabolism of catecholamines.
本报告描述了给新生大鼠注射[3H]6-羟基多巴胺([3H]6-OHDA)后氚标记物的分布情况。动物分别接受脑池内注射(i.c.)或皮下注射(s.c.),注射前有无用诺米芬辛预处理,诺米芬辛可阻断去甲肾上腺素(NA)和多巴胺(DA)的高亲和力摄取,并在注射后(p.i.)40分钟至24小时的不同时间点处死动物。在脑池内注射的动物中,注射后40分钟最早可在所有已知的NA和DA细胞群的神经元中检测到氚标记物。在NA神经元中,它被摄取到细胞体、树突、终末前和终末轴突中。神经元标记强度在注射后最初4小时内最高,大多数神经元在注射后间隔时间延长时强度降低。从注射后6小时开始,相当比例的NA和DA神经元发生变性,大多数在注射后24小时出现轴突反应的形态学迹象。未检测到[3H]6-OHDA被摄取到5-羟色胺能和非儿茶酚胺能神经元中。[3H]6-OHDA被中枢神经系统的以下神经外细胞积累:室管膜细胞、脉络丛上皮细胞、室管膜下巨噬细胞、实质内大血管壁的平滑肌细胞、脑膜细胞和神经胶质细胞。这些神经外成分中标记物积累和消失的时间进程各不相同。脑膜细胞显示出最高的标记强度,并在注射后24小时内发生变性。在用诺米芬辛预处理动物后,[3H]6-OHDA进入NA和DA神经元的摄取被完全阻断;相比之下,标记药物进入神经外细胞的摄取并未被阻止。这些发现表明,[3H]6-OHDA不仅被对NA或DA具有高亲和力摄取的神经元积累,还被许多其他参与儿茶酚胺代谢的神经外细胞积累。